Target intelligence / Profile preview

novel transcript, antisense to PATJ (ENSG00000298960)

Molecular classification
transcript, antisense RNA
01

Overview

The entry "novel transcript, antisense to PATJ" (ENSG00000298960) does not correspond to a well-characterized protein, receptor, enzyme, or any established therapeutic target. It appears to represent a computationally annotated transcript that is antisense to the well-known **PATJ** gene (Protein Associated to Tight Junctions), but there is no evidence in current databases or scientific literature that this antisense transcript encodes a protein, possesses a defined biological function, or is considered a therapeutic target[1][3][5]. There are no widely recognized aliases, standardized names, or therapeutic roles associated with this entity. The canonical PATJ gene itself is distinct, encodes a scaffolding protein involved in tight junctions and epithelial polarity, and carries clinical relevance, but this antisense transcript is not itself a validated or characterized molecular target[1][3][4][5]. If you seek structured data for the **canonical PATJ gene** or its protein product, refer to "PATJ Crumbs Cell Polarity Complex Component" (PATJ, ENSG00000132849), which is a distinct and well-annotated entity[1][3][5].

Beyond the preview

Go deeper on novel transcript, antisense to PATJ (ENSG00000298960).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to PATJ (ENSG00000298960).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call